Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids A randomized,..
本文档由 defa0bbc3f 分享于2020-05-14 10:24
Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids A randomized, placebo-con
分享:
君,已阅读到文档的结尾了呢~~